|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Flexible OLED encapsulated with gas barrier film and adhesive gasket显示文摘 | A Ra Cho Eun Hye Kim Soo Young Park Lee Soon Park | 2014 | Synthetic Metals2014，，： | 2 |
| 2 | Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein improves diagnostic accuracy for hepatocellular carcinoma显示文摘BACKGROUND Diagnostic accuracy of various tumor markers and their combinations for hepatocellular carcinoma(HCC)was not fully investigated.AIM To evaluate the diagnostic accuracy of alpha-fetoprotein(AFP),the Lens culinaris agglutinin-reactive fraction of AFP(AFP-L3),and protein induced by vitamin K absence or antagonist-II(PIVKA-II)and their combination for HCC diagnosis.METHODS Patients with newly detected liver mass or elevated serum AFP levels were considered eligible.Serum AFP level,AFP-L3 fraction,and PIVKA-II level were measured at the first visit.RESULTS In total,622 patients were included;355 patients(57.1%)had chronic liver disease,and 208(33.4%)had liver cirrhosis.HCC was diagnosed in 160 patients(25.7%).The area under the receiver operating characteristics curves(AUROCs)of the serum AFP,AFP-L3 fraction,AFP-L3,and PIVKA-II levels for the diagnosis of HCC were 0.775,0.792,0.814,and 0.834,respectively.A novel diagnostic model was developed by classifying patients in a 1:1 ratio into training and validation sets.Using the binary regression analysis of the training cohort,the AFP,AFP-L3 fraction,and PIVKA-II(ALPs)score was calculated as follows:ALPs score=3.8×[serum AFP level(ng/mL)×AFP-L3 fraction(%)×0.01]+0.2×PIVKA-II level(mAU/mL).The AUROC of the ALPs score for diagnosis of HCC was 0.878,significantly higher than that of serum AFP level(P<0.001),AFP-L3 fraction(P<0.001),PIVKA-II level(P=0.036),and AFP-L3 level(P=0.006).The optimal ALPs score cut-off was 5.3(sensitivity,85.0%,specificity 80.1%).The validation cohort showed similar results.CONCLUSION The ALPs score calculated using serum AFP level,AFP-L3 fraction,and PIVKA-II level showed improved accuracy in HCC diagnosis. | Han Ah Lee Yoo Ra Lee Young-Sun Lee Young Kul Jung Ji Hoon Kim Hyunggin An Hyung Joon Yim Yoon Tae Jeen Jong Eun Yeon Kwan Soo Byun Yeon Seok Seo | 2021 | World Journal of Gastroenterology2021，27，28： | 2 |
| 3 | Histological improvement following administration of autologous bone marrow‐derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study显示文摘 | Yoon Ok Jang Young Ju Kim Soon Koo Baik Moon Young Kim Young Woo Eom Mee Yon Cho Hong Jun Park So Yeon Park Bo Ra Kim Jae Woo Kim Hyun Soo Kim Sang Ok Kwon Eun Hee Choi Yong Man Kim | 2014 | Liver Int2014，，1： | 2 |
| 4 | TargetingROS1 with anaplastic lymphoma kinaseinhibitors: a promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer 显示文摘 | Chin LP1 Soo RA Soong R | 2012 | J Thorac Oncol2012，7，11： | 1 |
| 5 | Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC) 显示文摘 | Kumarakulasinghe NB van Zanwijk N Soo RA | 2015 | Respirology2015，20，3： | 1 |
| 6 | A multicentre randomised phaseⅡstudy of carboplat in in combination with gemcitabine at standard rate or fixed dose rate in fusion in patients with advanced stage non-small-cell lung cancer显示文摘 | Soo RA Wang LZ Thaml S | 2006 | Ann Oncol2006，17，7： | 1 |
| 7 | INSPIRE: a phaseⅢ study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stageⅢ non-small cell lung cancer显示文摘 | Wu YL Park K Soo RA | 2011 | BMC Cancer2011，11，1： | 1 |
| 8 | INSPIRE:A phase Ⅲ study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage Ⅲ non small ccll lung cancer显示文摘 | Wu YL Park K Soo RA | | 0，，： | 1 |
| 9 | Paclitaxel,5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma显示文摘 | Wong ASC Soo RA Lu JJ | | 0，，： | 1 |
| 10 | Phase Ⅰ trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study 显示文摘 | Lirm HL Wang LZ | 2003 | Cancer Chemother Pharmacol2003，52，2： | 1 |
| 11 | Targeting ROS1 with anaplastic lymph-oma kinase inhibitors: a promising therapeutic strategy for a newlydefined molecular subset of non-small-cell lung cancer 显示文摘 | Chin LP Soo RA Soong R | 2012 | J ThoracOncol2012，7，11： | 1 |
| 12 | Phase Ⅰ trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer:a cancer therapeutics research group study 显示文摘 | Soo RA Lim HL Wang LZ | 2003 | Cancer Chemother Pharmacol2003，52，2： | 1 |
| 13 | Purification and Characterization of Complement-activating Acidic Polysaccharides from the Fruits of Capsicum annuum显示文摘 | Soon-Young Paik Kyung Soo Ra Seop Chang | | 0，，： | 1 |
| 14 | INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer显示文摘 | Wu YL Park K Soo RA | 2011 | BMC Cancer2011，11，： | 1 |
| 15 | Best practice in the treatment of advanced squamous cell lung cancer显示文摘 | Ang YL Tan HL Soo RA | 2015 | Ther Adv RespirDis2015，9，5： | 1 |
| 16 | Personalized therapy on the horizon for squamous ceil carcinoma of the lung显示文摘 | Kim HS Mitsudomi T Soo RA | 2013 | Lung Cancer2013，80，3： | 1 |
| 17 | The Role of monoclonal antibody in combination with first-line chemotherapy in Asian patients with advanced non-small cell lung cancer显示文摘 | Cho BC Kim JH Soo RA | 2010 | Yonsei Med J2010，51，1： | 1 |
| 18 | Randomized phase Ⅱ study of carbopIatin and pachtaxel with either linifanib or placebo for advanced nonsquamous non-small-cell lung cancer 显示文摘 | Ramalingam SS Shtivelband M2 Soo RA | 2015 | J Clin Oncol2015，33，5： | 1 |
| 19 | Personalized therapy on the horizon for squamous eel/ carcinoma of the lung 显示文摘 | Kim I-IS Mitsudomi T Soo RA | 2013 | Lung Cancer2013，80，3： | 1 |
| 20 | Management of post-gastrectomy anastomosis site obstruction with a self-expandable metallic stent显示文摘Post-gastrectomy anastomosis site obstruction is a relatively rare complication after a subtotal gastrectomy.We present a case of a 75-year-old man who underwent a truncal vagotomy, omental patch, gastrojejunostomy, and Braun anastomosis for duodenal ulcer perforation and a gastric outlet obstruction.Following the 10 th postoperative day, the patient complained of abdominal discomfort and vomiting.We diagnosed post-gastrectomy anastomosis site obstruction by an upper gastrointestinal series and an upper endoscopic examination.We inserted a self-expandable metallic stent(SEMS) at the anastomosis site.The stent was fully expanded after deployment.On the day following the stent insertion, the patient began to eat, and his abdominal discomfort was resolved.This paper describes the successful management of post-gastrectomy anastomosis site obstruction with temporary placement of a SEMS. | Ra Ri Cha Sang Soo Lee Hyunjin Kim Hong Jun Kim Tae-Hyo Kim Woon Tae Jung Ok Jae Lee Kyung Soo Bae Sang-Ho Jeong Chang Yoon Ha | 2015 | World Journal of Gastroenterology2015，21，16： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员